Impact of physical and clinical complications on the time required to perform lower limb functional activities in a boy with Duchenne muscular dystrophy: case study
DOI:
https://doi.org/10.62827/fb.v25i5.1031Keywords:
Evaluation study; muscular dystrophies; child.Abstract
Introduction: The set of activities of getting up and sitting on the floor and on a chair, going up and down stairs and walking are essential for the patient's independence and mobility, and their assessment is of great clinical relevance for the functional monitoring of children diagnosed with Duchenne muscular dystrophy. Objective: To describe the relationship between the time taken to perform lower limb motor activities and physical and clinical complications in a boy with Duchenne muscular dystrophy, monitored fortnightly for a period of one year. Methods: The participant was chosen from a set of 182 medical records. The inclusion criteria were having completed the one-year period performing the functional activities to be analyzed, having attended all biweekly physical therapy sessions in the one-year period and having a history of physical and clinical complications in the anamnesis. The times taken to perform the functional activities were systematically timed and complications such as falls and flu were investigated. The activities of getting up from the floor and from a chair, going up and down stairs and walking were evaluated. Results: Minor physical and clinical complications increased the time spent performing activities with a temporary worsening of motor functions, but did not alter the observed progressive course of the disease. After the events, the data returned to the expected evolution line, characteristic of Duchenne muscular dystrophy. The collection and contextualized interpretation of the times to perform motor activities was essential for immediate clinical decision-making, assisting in the choice of appropriate physical therapy intervention for the patient. Conclusion: Measuring the time to perform lower limb motor activities was relevant in understanding the current clinical-functional state of the patient at the time of the physical therapy intervention, especially when contextualized with situations of physical and clinical complications. We suggest these assessment measures in clinical physiotherapy routines, focusing on at least one of the functional activities, since collecting multiple measures compromises the time of care in the session.
References
Vignos PJ Jr, Spencer GE Jr, Archibald KC. Management of progressive muscular dystrophy in childhood. JAMA. 1963; 184: 89-96. http://dx.doi.org/10.1001/jama.1963.03700150043007.
Darras BT, Urion DK, Ghosh PS. Dystrophinopathies. 2000 Sep 5 [Updated 2022 Jan 20]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1119/
Fernandes LA, Caromano FA, Hukuda ME, Escorcio R, Carvalho EV. Elaboration and reliability of functional evaluation on going up and downstairs scale for Duchenne Muscular Dystrophy. Rev Bras Fisioter. 2010;14(6):518-26. http://dx.doi.org/10.1590/S1413-35552010000600011.
Escorcio R, Caromano FA, Hukuda ME, Fernandes LA. Development of an evaluation scale for sitting and standing from the ground for children with Duchenne muscular dystrophy. J Mot Behav. 2011;43(1):31-6. http://dx.doi.org/10.1080/00222895.2010.530306.
Hukuda ME, Escorcio R, Fernandes LA, de Carvalho EV, Caromano FA. Evaluation scale development, reliability for sitting and standing from the chair for Duchenne muscular dystrophy. J Mot Behav. 2013;45(2):117-26. http://dx.doi.org/10.1080/00222895.2012.760513.
Vignos, P J, and Watkins, M P. The effect of exercise in muscular dystrophy. JAMA 1966; 197 (11), 843. http://dx.doi.org/10.1001/jama.1966.03110110067015.
Su Y and Song Y. The new challenge of “exercise + X″ therapy for Duchenne muscular dystrophy—Individualized identification of exercise tolerance and precise implementation of exercise intervention. Front. Physiol. 2022; 13:947749. http://dx.doi.org/10.3389/fphys.2022.94774.
Grange RW, and Call JA. Recommendations to define exercise prescription for Duchenne muscular dystrophy. Exerc. Sport Sci. Rev. 2007; 35 (1), 12–17. http://dx.doi.org/10.1249/01.jes.0000240020.84630.9d.
Sejerson T, and Bushby K. Standards of care for Duchenne muscular dystrophy: brief TREAT-NMD recommendations. Adv. Exp. Med. Biol. 2009; 652, 13–21. http://dx.doi.org/10.1007/978-90-481-2813-6_2.
Markert C D, Ambrosio F, Call JA, and Grange RW. Exercise and Duchenne muscular dystrophy: toward evidence-based exercise prescription. Muscle Nerve 2011; 43 (4), 464–478. http://dx.doi.org/10.1002/mus.21987.
Shi W. Progress in the evaluation of motor function and clinical application of Duchenne muscular dystrophy research. Chin. J. Mod. Neuropathy 2015; 15 (06), 426–431. http://dx.doi.org/10.3969/j.issn.1672-6731.2015.06.002.
Viscomi F. Diagnóstico clínico e diagnóstico anatomopatológico: discordâncias. Rev. Assoc. Med. Bras. 50 (2) • Abr 2004 https://doi.org/10.1590/S0104-42302004000200023.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Fernando Alves Vale , Mariana Callil Voos , Fátima Aparecida Caromano (Autor)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution 4.0 que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
Autores têm autorização para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.